Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer

Translational Research

Volumn 181, Issue , 2017, Pages 108-120

  Weng, Mingjiao ^a   Wu, Di ^b   Yang, Chao ^a   Peng, Haisheng ^a   Wang, Guangyu ^a   Wang, Tianzhen ^a   Li, Xiaobo ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; SMALL NUCLEOLAR RNA; UNTRANSLATED RNA; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; COLORECTAL CANCER; DISEASE COURSE; GENE FUNCTION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOGENE; REGULATORY MECHANISM; REVIEW; RNA ANALYSIS; CARCINOGENESIS; COLORECTAL NEOPLASMS; GENETICS; METABOLISM; PATHOLOGY; TREATMENT OUTCOME;

BIOMARKERS, TUMOR; CARCINOGENESIS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; RNA, UNTRANSLATED; TREATMENT OUTCOME;

EID: 85006102794     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2016.10.001     Document Type: Review

References (169)

1. 1 International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431 (2004), 931–945.
2. 2 Hattori, M., (Trans.) Finishing the euchromatic sequence of the human genome Tanpakushitsu Kakusan Koso 50 (2005), 162–168.
3. 3 Kapranov, P., Drenkow, J., Cheng, J., et al. Examples of the complex architecture of the human transcriptome revealed by race and high-density tiling arrays. Genome Res 15 (2005), 987–997.
4. 4 Yang, C., Wu, D., Gao, L., et al. Competing endogenous rna networks in human cancer: hypothesis, validation, and perspectives. Oncotarget 7 (2016), 13479–13490.
5. 5 Carthew, R.W., Sontheimer, E.J., Origins and mechanisms of mirnas and sirnas. Cell 136 (2009), 642–655.
6. 6 Maass, P.G., Luft, F.C., Bahring, S., Long non-coding rna in health and disease. J Mol Med 92 (2014), 337–346.
7. 7 Taft, R.J., Pang, K.C., Mercer, T.R., et al. Non-coding rnas: regulators of disease. J Pathol 220 (2010), 126–139.
8. 8 Ferlay, J., Shin, H.R., Bray, F., et al. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 127 (2010), 2893–2917.
9. 9 Ragusa, M., Barbagallo, C., Statello, L., et al. Non-coding landscapes of colorectal cancer. World J Gastroenterol 21 (2015), 11709–11739.
10. 10 Wang, J., Song, Y.X., Ma, B., et al. Regulatory roles of non-coding rnas in colorectal cancer. Int J Mol Sci 16 (2015), 19886–19919.
11. 11 Lasda, E., Parker, R., Circular rnas: diversity of form and function. RNA 20 (2014), 1829–1842.
12. 12 Sana, J., Faltejskova, P., Svoboda, M., et al. Novel classes of non-coding rnas and cancer. J Transl Med, 10, 2012, 103.
13. 13 Fabian, M.R., Sonenberg, N., Filipowicz, W., Regulation of mrna translation and stability by micrornas. Annu Rev Biochem 79 (2010), 351–379.
14. 14 Thomson, T., Lin, H., The biogenesis and function of piwi proteins and pirnas: Progress and prospect. Annu Rev Cell Dev Biol 25 (2009), 355–376.
15. 15 Kiss, T., Small nucleolar rnas: an abundant group of noncoding rnas with diverse cellular functions. Cell 109 (2002), 145–148.
16. 16 Ender, C., Krek, A., Friedlander, M.R., et al. A human snorna with microrna-like functions. Mol Cell 32 (2008), 519–528.
17. 17 Imamura, T., Yamamoto, S., Ohgane, J., et al. Non-coding rna directed DNA demethylation of sphk1 cpg island. Biochem Biophys Res Commun 322 (2004), 593–600.
18. 18 Wang, K.C., Chang, H.Y., Molecular mechanisms of long noncoding rnas. Mol Cell 43 (2011), 904–914.
19. 19 Paraskevopoulou, M.D., Georgakilas, G., Kostoulas, N., et al. Diana-lncbase: Experimentally verified and computationally predicted microrna targets on long non-coding rnas. Nucleic Acids Res 41 (2013), D239–D245.
20. 20 D'Errico, I., Gadaleta, G., Saccone, C., Pseudogenes in metazoa: Origin and features. Brief Funct Genomic Proteomic 3 (2004), 157–167.
21. 21 Liedtke, S., Enczmann, J., Waclawczyk, S., et al. Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 1 (2007), 364–366.
22. 22 Swami, M., Small rnas: pseudogenes act as microrna decoys. Nat Rev Genet 11 (2010), 530–531.
23. 23 Tam, O.H., Aravin, A.A., Stein, P., et al. Pseudogene-derived small interfering rnas regulate gene expression in mouse oocytes. Nature 453 (2008), 534–538.
24. 24 Hollander, M.C., Blumenthal, G.M., Dennis, P.A., Pten loss in the continuum of common cancers, rare syndromes and mouse models. Nature reviews. Cancer 11 (2011), 289–301.
25. 25 Karreth, F.A., Tay, Y., Perna, D., et al. In vivo identification of tumor- suppressive pten cernas in an oncogenic braf-induced mouse model of melanoma. Cell 147 (2011), 382–395.
26. 26 Memczak, S., Jens, M., Elefsinioti, A., et al. Circular rnas are a large class of animal rnas with regulatory potency. Nature 495 (2013), 333–338.
27. 27 Ito, M., Mitsuhashi, K., Igarashi, H., et al. Microrna-31 expression in relation to braf mutation, cpg island methylation and colorectal continuum in serrated lesions. Int J Cancer 135 (2014), 2507–2515.
28. 28 Colussi, D., Brandi, G., Bazzoli, F., et al. Molecular pathways involved in colorectal cancer: Implications for disease behavior and prevention. Int J Mol Sci 14 (2013), 16365–16385.
29. 29 Okayama, H., Schetter, A.J., Harris, C.C., Micrornas and inflammation in the pathogenesis and progression of colon cancer. Dig Dis 30 (2012), 9–15.
30. 30 Wang, G., Li, Z., Zhao, Q., et al. Lincrna-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the wnt/beta-catenin signaling pathway. Oncol Rep 31 (2014), 1839–1845.
31. 31 Iliopoulos, D., Jaeger, S.A., Hirsch, H.A., et al. Stat3 activation of mir-21 and mir-181b-1 via pten and cyld are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39 (2010), 493–506.
32. 32 Lu, Z., Liu, M., Stribinskis, V., et al. Microrna-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27 (2008), 4373–4379.
33. 33 Sayed, D., Rane, S., Lypowy, J., et al. Microrna-21 targets sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19 (2008), 3272–3282.
34. 34 Liu, Q., Huang, J., Zhou, N., et al. Lncrna loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 41 (2013), 4976–4987.
35. 35 Graham, L.D., Pedersen, S.K., Brown, G.S., et al. Colorectal neoplasia differentially expressed (crnde), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes Cancer 2 (2011), 829–840.
36. 36 Michael, M.Z., O' Connor, S.M., van Holst Pellekaan, N.G., et al. Reduced accumulation of specific micrornas in colorectal neoplasia. Mol Cancer Res 1 (2003), 882–891.
37. 37 Wang, C.J., Zhou, Z.G., Wang, L., et al. Clinicopathological significance of microrna-31, -143 and -145 expression in colorectal cancer. Dis Markers 26 (2009), 27–34.
38. 38 Pekow, J.R., Dougherty, U., Mustafi, R., et al. Mir-143 and mir-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis 18 (2012), 94–100.
39. 39 Pagliuca, A., Valvo, C., Fabrizi, E., et al. Analysis of the combined action of mir-143 and mir-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene 32 (2013), 4806–4813.
40. 40 Chen, X., Guo, X., Zhang, H., et al. Role of mir-143 targeting kras in colorectal tumorigenesis. Oncogene 28 (2009), 1385–1392.
41. 41 Sachdeva, M., Zhu, S., Wu, F., et al. P53 represses c-myc through induction of the tumor suppressor mir-145. Proc Natl Acad Sci U S A 106 (2009), 3207–3212.
42. 42 Iliou, M.S., da Silva-Diz, V., Carmona, F.J., et al. Impaired dicer1 function promotes stemness and metastasis in colon cancer. Oncogene 33 (2014), 4003–4015.
43. 43 Gregory, P.A., Bert, A.G., Paterson, E.L., et al. The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat Cell Biol 10 (2008), 593–601.
44. 44 Park, S.M., Gaur, A.B., Lengyel, E., et al. The mir-200 family determines the epithelial phenotype of cancer cells by targeting the e-cadherin repressors zeb1 and zeb2. Genes Dev 22 (2008), 894–907.
45. 45 Burk, U., Schubert, J., Wellner, U., et al. A reciprocal repression between zeb1 and members of the mir-200 family promotes emt and invasion in cancer cells. EMBO Rep 9 (2008), 582–589.
46. 46 Hur, K., Toiyama, Y., Takahashi, M., et al. Microrna-200c modulates epithelial-to-mesenchymal transition (emt) in human colorectal cancer metastasis. Gut 62 (2013), 1315–1326.
47. 47 Tian, Y., Pan, Q., Shang, Y., et al. Microrna-200 (mir-200) cluster regulation by achaete scute-like 2 (ascl2): Impact on the epithelial-mesenchymal transition in colon cancer cells. J Biol Chem 289 (2014), 36101–36115.
48. 48 Mateescu, B., Batista, L., Cardon, M., et al. Mir-141 and mir-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 17 (2011), 1627–1635.
49. 49 Korpal, M., Ell, B.J., Buffa, F.M., et al. Direct targeting of sec23a by mir-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17 (2011), 1101–1108.
50. 50 Cui, H., Onyango, P., Brandenburg, S., et al. Loss of imprinting in colorectal cancer linked to hypomethylation of h19 and igf2. Cancer Res 62 (2002), 6442–6446.
51. 51 Tsang, W.P., Ng, E.K., Ng, S.S., et al. Oncofetal h19-derived mir-675 regulates tumor suppressor rb in human colorectal cancer. Carcinogenesis 31 (2010), 350–358.
52. 52 Liang, W.C., Fu, W.M., Wong, C.W., et al. The lncrna h19 promotes epithelial to mesenchymal transition by functioning as mirna sponges in colorectal cancer. Oncotarget 6 (2015), 22513–22525.
53. 53 Ling, H., Spizzo, R., Atlasi, Y., et al. Ccat2, a novel noncoding rna mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res 23 (2013), 1446–1461.
54. 54 Xu, C., Yang, M., Tian, J., et al. Malat-1: a long non-coding rna and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol 39 (2011), 169–175.
55. 55 Ji, Q., Zhang, L., Liu, X., et al. Long non-coding rna malat1 promotes tumour growth and metastasis in colorectal cancer through binding to sfpq and releasing oncogene ptbp2 from sfpq/ptbp2 complex. Br J Cancer 111 (2014), 736–748.
56. 56 Hu, Z.Y., Wang, X.Y., Guo, W.B., et al. Long non-coding rna malat1 increases akap-9 expression by promoting srpk1-catalyzed srsf1 phosphorylation in colorectal cancer cells. Oncotarget 7 (2016), 11733–11743.
57. 57 Xiang, J.F., Yin, Q.F., Chen, T., et al. Human colorectal cancer-specific ccat1-l lncrna regulates long-range chromatin interactions at the myc locus. Cell Res 24 (2014), 513–531.
58. 58 He, X., Tan, X., Wang, X., et al. C-myc-activated long noncoding rna ccat1 promotes colon cancer cell proliferation and invasion. Tumour Biol 35 (2014), 12181–12188.
59. 59 Merry, C.R., Forrest, M.E., Sabers, J.N., et al. Dnmt1-associated long non-coding rnas regulate global gene expression and DNA methylation in colon cancer. Hum Mol Genet 24 (2015), 6240–6253.
60. 60 Taniue, K., Kurimoto, A., Sugimasa, H., et al. Long noncoding rna upat promotes colon tumorigenesis by inhibiting degradation of uhrf1. Proc Natl Acad Sci U S A 113 (2016), 1273–1278.
61. 61 Qiu, M., Xu, Y., Yang, X., et al. Ccat2 is a lung adenocarcinoma-specific long non-coding rna and promotes invasion of non-small cell lung cancer. Tumour Biol 35 (2014), 5375–5380.
62. 62 Zhou, J., Li, X., Wu, M., et al. Knockdown of long noncoding rna ghet1 inhibits cell proliferation and invasion of colorectal cancer. Oncol Res 23 (2016), 303–309.
63. 63 Sun, J., Ding, C., Yang, Z., et al. The long non-coding rna tug1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition. J Transl Med, 14, 2016, 42.
64. 64 Gupta, R.A., Shah, N., Wang, K.C., et al. Long non-coding rna hotair reprograms chromatin state to promote cancer metastasis. Nature 464 (2010), 1071–1076.
65. 65 Wu, Z.H., Wang, X.L., Tang, H.M., et al. Long non-coding rna hotair is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep 32 (2014), 395–402.
66. 66 Kogo, R., Shimamura, T., Mimori, K., et al. Long noncoding rna hotair regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71 (2011), 6320–6326.
67. 67 Li, Y., Li, Y., Chen, W., et al. Neat expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget 6 (2015), 27641–27650.
68. 68 Yang, P., Chen, T., Xu, Z., et al. Long noncoding rna gaplinc promotes invasion in colorectal cancer by targeting snai2 through binding with psf and nono. Oncotarget, 2016.
69. 69 Yang, P., Xu, Z.P., Chen, T., et al. Long noncoding rna expression profile analysis of colorectal cancer and metastatic lymph node based on microarray data. Onco Targets Ther 9 (2016), 2465–2478.
70. 70 Niu, H., Hu, Z., Liu, H., et al. Long non-coding rna ak027294 involves in the process of proliferation, migration, and apoptosis of colorectal cancer cells. Tumour Biol 37 (2016), 10097–10105.
71. 71 Thorenoor, N., Faltejskova-Vychytilova, P., Hombach, S., et al. Long non-coding rna zfas1 interacts with cdk1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget 7 (2016), 622–637.
72. 72 Marin-Bejar, O., Marchese, F.P., Athie, A., et al. Pint lincrna connects the p53 pathway with epigenetic silencing by the polycomb repressive complex 2. Genome Biol, 14, 2013, R104.
73. 73 Shi, Y., Liu, Y., Wang, J., et al. Downregulated long noncoding rna bancr promotes the proliferation of colorectal cancer cells via downregualtion of p21 expression. PLoS One, 10, 2015, e0122679.
74. 74 Takahashi, Y., Sawada, G., Kurashige, J., et al. Amplification of pvt-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 110 (2014), 164–171.
75. 75 Wang, F., Ni, H., Sun, F., et al. Overexpression of lncrna afap1-as1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer. Biomed Pharmacother 81 (2016), 152–159.
76. 76 Ma, Y., Yang, Y., Wang, F., et al. Long non-coding rna ccal regulates colorectal cancer progression by activating wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha. Gut 65 (2016), 1494–1504.
77. 77 Yuan, Z., Yu, X., Ni, B., et al. Overexpression of long non-coding rna-ctd903 inhibits colorectal cancer invasion and migration by repressing wnt/beta-catenin signaling and predicts favorable prognosis. Int J Oncol 48 (2016), 2675–2685.
78. 78 Zhang, Z., Zhou, C., Chang, Y., et al. Long non-coding RNA casc11 interacts with hnrnp-k and activates the wnt/beta-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Lett 376 (2016), 62–73.
79. 79 Zhang, Z.Y., Lu, Y.X., Zhang, Z.Y., et al. Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer. Oncotarget 7 (2016), 22639–22649.
80. 80 Chen, N., Guo, D., Xu, Q., et al. Long non-coding rna fezf1-as1 facilitates cell proliferation and migration in colorectal carcinoma. Oncotarget 7 (2016), 11271–11283.
81. 81 Liu, B., Shen, E.D., Liao, M.M., et al. Expression and mechanisms of long non-coding rna genes meg3 and anril in gallbladder cancer. Tumour Biol 37 (2016), 9875–9886.
82. 82 Wu, X., He, X., Li, S., et al. Long non-coding rna ucoo2kmd.1 regulates cd44-dependent cell growth by competing for mir-211-3p in colorectal cancer. PLoS One, 11, 2016, e0151287.
83. 83 Sun, L., Xue, H., Jiang, C., et al. Lncrna dq786243 contributes to proliferation and metastasis of colorectal cancer both in vitro and in vivo. Biosci Rep, 36, 2016.
84. 84 Han, D., Gao, X., Wang, M., et al. Long noncoding rna h19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eif4a3. Oncotarget 7 (2016), 22159–22173.
85. 85 Liu, T., Zhang, X., Yang, Y.M., et al. Increased expression of the long noncoding rna crnde-h indicates a poor prognosis in colorectal cancer, and is positively correlated with irx5 mrna expression. Onco Targets Ther 9 (2016), 1437–1448.
86. 86 Huang, G., Wu, X., Li, S., et al. The long noncoding rna casc2 functions as a competing endogenous rna by sponging mir-18a in colorectal cancer. Sci Rep, 6, 2016, 26524.
87. 87 Wang, L., Bu, P., Ai, Y., et al. A long non-coding rna targets microrna mir-34a to regulate colon cancer stem cell asymmetric division. Elife, 5, 2016.
88. 88 Bian, Z., Jin, L., Zhang, J., et al. Lncrna-uca1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting mir-204-5p. Sci Rep, 6, 2016, 23892.
89. 89 Yue, B., Sun, B., Liu, C., et al. Long non-coding rna fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with mir-106a-5p in colon cancer. Cancer Sci 106 (2015), 1323–1332.
90. 90 Yan, B., Gu, W., Yang, Z., et al. Downregulation of a long noncoding rna-ncrupar contributes to tumor inhibition in colorectal cancer. Tumour Biol 35 (2014), 11329–11335.
91. 91 Nakano, S., Murakami, K., Meguro, M., et al. Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers. Cancer Sci 97 (2006), 1147–1154.
92. 92 Sunamura, N., Ohira, T., Kataoka, M., et al. Regulation of functional KCNQ1OT1 lncRNA by beta-catenin. Sci Rep, 6, 2016, 20690.
93. 93 Kumegawa, K., Maruyama, R., Yamamoto, E., et al. A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer. Sci Rep, 6, 2016, 26699.
94. 94 Yang, L., Qiu, M., Xu, Y., et al. Upregulation of long non-coding RNA PRNCR1 in colorectal cancer promotes cell proliferation and cell cycle progression. Oncol Rep 35 (2016), 318–324.
95. 95 Ding, J., Lu, B., Wang, J., et al. Long non-coding RNA Loc554202 induces apoptosis in colorectal cancer cells via the caspase cleavage cascades. J Exp Clin Cancer Res, 34, 2015, 100.
96. 96 Han, Y.J., Ma, S.F., Yourek, G., et al. A transcribed pseudogene of mylk promotes cell proliferation. FASEB J 25 (2011), 2305–2312.
97. 97 Ye, X., Fan, F., Bhattacharya, R., et al. Vegfr-1 pseudogene expression and regulatory function in human colorectal cancer cells. Mol Cancer Res 13 (2015), 1274–1282.
98. 98 Bachmayr-Heyda, A., Reiner, A.T., Auer, K., et al. Correlation of circular rna abundance with proliferation–exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep, 5, 2015, 8057.
99. 99 Wang, X., Zhang, Y., Huang, L., et al. Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances. Int J Clin Exp Pathol 8 (2015), 16020–16025.
100. 100 Okugawa, Y., Toiyama, Y., Toden, S., et al. Clinical significance of snora42 as an oncogene and a prognostic biomarker in colorectal cancer. Gut, 2015.
101. 101 Shen, K., Mao, R., Ma, L., et al. Post-transcriptional regulation of the tumor suppressor mir-139-5p and a network of mir-139-5p-mediated mrna interactions in colorectal cancer. FEBS J 281 (2014), 3609–3624.
102. 102 Kudryavtseva, A.V., Lipatova, A.V., Zaretsky, A.R., et al. Important molecular genetic markers of colorectal cancer. Oncotarget, 2016.
103. 103 Xu, M.D., Qi, P., Du, X., Long non-coding rnas in colorectal cancer: Implications for pathogenesis and clinical application. Mod Pathol 27 (2014), 1310–1320.
104. 104 Ng, E.K., Chong, W.W., Jin, H., et al. Differential expression of micrornas in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58 (2009), 1375–1381.
105. 105 Cheng, H., Zhang, L., Cogdell, D.E., et al. Circulating plasma mir-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One, 6, 2011, e17745.
106. 106 Yong, F.L., Law, C.W., Wang, C.W., Potentiality of a triple microrna classifier: mir-193a-3p, mir-23a and mir-338-5p for early detection of colorectal cancer. BMC Cancer, 13, 2013, 280.
107. 107 Aherne, S.T., Madden, S.F., Hughes, D.J., et al. Circulating mirnas mir-34a and mir-150 associated with colorectal cancer progression. BMC Cancer, 15, 2015, 329.
108. 108 Ogata-Kawata, H., Izumiya, M., Kurioka, D., et al. Circulating exosomal micrornas as biomarkers of colon cancer. PLoS One, 9, 2014, e92921.
109. 109 Beckett, E.L., Martin, C., Choi, J.H., et al. Folate status, folate-related genes and serum mir-21 expression: Implications for mir-21 as a biomarker. BBA Clin 4 (2015), 45–51.
110. 110 Ahmed, F.E., Ahmed, N.C., Vos, P.W., et al. Diagnostic microrna markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics 10 (2013), 93–113.
111. 111 Wu, C.W., Ng, S.C., Dong, Y., et al. Identification of microrna-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma. Clin Cancer Res 20 (2014), 2994–3002.
112. 112 Nissan, A., Stojadinovic, A., Mitrani-Rosenbaum, S., et al. Colon cancer associated transcript-1: a novel rna expressed in malignant and pre-malignant human tissues. Int J Cancer 130 (2012), 1598–1606.
113. 113 Alaiyan, B., Ilyayev, N., Stojadinovic, A., et al. Differential expression of colon cancer associated transcript1 (ccat1) along the colonic adenoma-carcinoma sequence. BMC Cancer, 13, 2013, 196.
114. 114 Kam, Y., Rubinstein, A., Naik, S., et al. Detection of a long non-coding rna (ccat1) in living cells and human adenocarcinoma of colon tissues using fit-pna molecular beacons. Cancer Lett 352 (2014), 90–96.
115. 115 Pedersen, S.K., Mitchell, S.M., Graham, L.D., et al. Cahm, a long non-coding rna gene hypermethylated in colorectal neoplasia. Epigenetics 9 (2014), 1071–1082.
116. 116 Xi, Y., Formentini, A., Chien, M., et al. Prognostic values of micrornas in colorectal cancer. Biomark Insights 2 (2006), 113–121.
117. 117 Chen, J., Wang, W., Zhang, Y., et al. Predicting distant metastasis and chemoresistance using plasma mirnas. Med Oncol, 31, 2014, 799.
118. 118 Toiyama, Y., Hur, K., Tanaka, K., et al. Serum mir-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg 259 (2014), 735–743.
119. 119 Fang, L., Li, H., Wang, L., et al. Microrna-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing pten expression. Oncotarget 5 (2014), 2974–2987.
120. 120 Rapti, S.M., Kontos, C.K., Papadopoulos, I.N., et al. High mir-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis. Tumour Biol 9 (2016), 11815–11824.
121. 121 Pu, X.X., Huang, G.L., Guo, H.Q., et al. Circulating mir-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 25 (2010), 1674–1680.
122. 122 Liu, G.H., Zhou, Z.G., Chen, R., et al. Serum mir-21 and mir-92a as biomarkers in the diagnosis and prognosis of colorectal cancer. Tumour Biol 34 (2013), 2175–2181.
123. 123 Brunet Vega, A., Pericay, C., Moya, I., et al. Microrna expression profile in stage iii colorectal cancer: Circulating mir-18a and mir-29a as promising biomarkers. Oncol Rep 30 (2013), 320–326.
124. 124 Toiyama, Y., Takahashi, M., Hur, K., et al. Serum mir-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 105 (2013), 849–859.
125. 125 Yu, H., Gao, G., Jiang, L., et al. Decreased expression of mir-218 is associated with poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 6 (2013), 2904–2911.
126. 126 Lv, Z.C., Fan, Y.S., Chen, H.B., et al. Investigation of microrna-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. Tumour Biol 36 (2015), 1619–1625.
127. 127 Liu, M., Zhi, Q., Wang, W., et al. Up-regulation of mir-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. Biomed Pharmacother 69 (2015), 214–220.
128. 128 Matsumura, T., Sugimachi, K., Iinuma, H., et al. Exosomal microrna in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer 113 (2015), 275–281.
129. 129 Yu, J., Jin, L., Jiang, L., et al. Serum mir-372 is a diagnostic and prognostic biomarker in patients with early colorectal cancer. Anticancer Agents Med Chem 16 (2016), 424–431.
130. 130 Kjersem, J.B., Ikdahl, T., Lingjaerde, O.C., et al. Plasma micrornas predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment. Mol Oncol 8 (2014), 59–67.
131. 131 Yang, I.P., Tsai, H.L., Huang, C.W., et al. The functional significance of microrna-29c in patients with colorectal cancer: A potential circulating biomarker for predicting early relapse. PLoS One, 8, 2013, e66842.
132. 132 Tsai, H.L., Yang, I.P., Huang, C.W., et al. Clinical significance of microrna-148a in patients with early relapse of stage ii stage and iii colorectal cancer after curative resection. Transl Res 162 (2013), 258–268.
133. 133 Shivapurkar, N., Weiner, L.M., Marshall, J.L., et al. Recurrence of early stage colon cancer predicted by expression pattern of circulating micrornas. PLoS One, 9, 2014, e84686.
134. 134 Hansen, T.F., Carlsen, A.L., Heegaard, N.H., et al. Changes in circulating microrna-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer. Br J Cancer 112 (2015), 624–629.
135. 135 Svoboda, M., Slyskova, J., Schneiderova, M., et al. Hotair long non-coding rna is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis 35 (2014), 1510–1515.
136. 136 Qi, P., Xu, M.D., Ni, S.J., et al. Low expression of loc285194 is associated with poor prognosis in colorectal cancer. J Transl Med, 11, 2013, 122.
137. 137 Iguchi, T., Uchi, R., Nambara, S., et al. A long noncoding rna, lncrna-atb, is involved in the progression and prognosis of colorectal cancer. Anticancer Res 35 (2015), 1385–1388.
138. 138 Qu, S., Yang, X., Song, W., et al. Downregulation of lncrna-atb correlates with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol 37 (2016), 3933–3938.
139. 139 Yin, D.D., Liu, Z.J., Zhang, E., et al. Decreased expression of long noncoding rna meg3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumour Biol 36 (2015), 4851–4859.
140. 140 Yin, D., He, X., Zhang, E., et al. Long noncoding rna gas5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol, 31, 2014, 253.
141. 141 Ge, X., Chen, Y., Liao, X., et al. Overexpression of long noncoding rna pcat-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med Oncol, 30, 2013, 588.
142. 142 Shi, D., Zheng, H., Zhuo, C., et al. Low expression of novel lncrna rp11-462c24.1 suggests a biomarker of poor prognosis in colorectal cancer. Med Oncol, 31, 2014, 31.
143. 143 Zheng, H.T., Shi, D.B., Wang, Y.W., et al. High expression of lncrna malat1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol 7 (2014), 3174–3181.
144. 144 Deng, Q., He, B., Gao, T., et al. Up-regulation of 91h promotes tumor metastasis and predicts poor prognosis for patients with colorectal cancer. PLoS One, 9, 2014, e103022.
145. 145 Qiu, J.J., Yan, J.B., Long non-coding rna linc01296 is a potential prognostic biomarker in patients with colorectal cancer. Tumour Biol 36 (2015), 7175–7183.
146. 146 Cheng, J., Guo, J.M., Xiao, B.X., et al. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta 412 (2011), 1621–1625.
147. 147 Dong, X.Y., Rodriguez, C., Guo, P., et al. Snorna u50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet 17 (2008), 1031–1042.
148. 148 Tanaka, R., Satoh, H., Moriyama, M., et al. Intronic u50 small-nucleolar-rna (snorna) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human b-cell lymphoma. Genes Cells 5 (2000), 277–287.
149. 149 Mei, Y.P., Liao, J.P., Shen, J., et al. Small nucleolar rna 42 acts as an oncogene in lung tumorigenesis. Oncogene 31 (2012), 2794–2804.
150. 150 Liao, J., Yu, L., Mei, Y., et al. Small nucleolar rna signatures as biomarkers for non-small-cell lung cancer. Mol Cancer, 9, 2010, 198.
151. 151 Gee, H.E., Buffa, F.M., Camps, C., et al. The small-nucleolar rnas commonly used for microrna normalisation correlate with tumour pathology and prognosis. Br J Cancer 104 (2011), 1168–1177.
152. 152 Affymetrix, E.T., Cold Spring Harbor Laboratory ETP. Post-transcriptional processing generates a diversity of 5'-modified long and short rnas. Nature 457 (2009), 1028–1032.
153. 153 Hawkins, P.G., Santoso, S., Adams, C., et al. Promoter targeted small rnas induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res 37 (2009), 2984–2995.
154. 154 Taft, R.J., Hawkins, P.G., Mattick, J.S., et al. The relationship between transcription initiation rnas and ccctc-binding factor (ctcf) localization. Epigenetics Chromatin, 4, 2011, 13.
155. 155 Wang, X., Arai, S., Song, X., et al. Induced ncrnas allosterically modify rna-binding proteins in cis to inhibit transcription. Nature 454 (2008), 126–130.
156. 156 Manikandan, M., Munirajan, A.K., Single nucleotide polymorphisms in microrna binding sites of oncogenes: Implications in cancer and pharmacogenomics. OMICS 18 (2014), 142–154.
157. 157 He, H., Liyanarachchi, S., Akagi, K., et al. Mutations in u4atac snrna, a component of the minor spliceosome, in the developmental disorder mopd i. Science 332 (2011), 238–240.
158. 158 Chen, X., Ba, Y., Ma, L., et al. Characterization of micrornas in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18 (2008), 997–1006.
159. 159 Peng, J., Xie, Z., Cheng, L., et al. Paired design study by real-time pcr: Mir-378* and mir-145 are potent early diagnostic biomarkers of human colorectal cancer. BMC Cancer, 15, 2015, 158.
160. 160 Kong, H., Zhu, M., Cui, F., et al. Quantitative assessment of short amplicons in ffpe-derived long-chain rna. Sci Rep, 4, 2014, 7246.
161. 161 Wu, Y., Yang, L., Zhao, J., et al. Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer. Mol Cancer, 14, 2015, 191.
162. 162 Ramalingam, S., Subramaniam, D., Anant, S., Manipulating mirna expression: A novel approach for colon cancer prevention and chemotherapy. Curr Pharmacol Rep 1 (2015), 141–153.
163. 163 Bertoli, G., Cava, C., Castiglioni, I., Micrornas: New biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics 5 (2015), 1122–1143.
164. 164 Bekeredjian, R., Grayburn, P.A., Shohet, R.V., Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 45 (2005), 329–335.
165. 165 Wood, A.K., Sehgal, C.M., A review of low-intensity ultrasound for cancer therapy. Ultrasound Med Biol 41 (2015), 905–928.
166. 166 Ogino, S., Nishihara, R., VanderWeele, T.J., et al. Review article: The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology 27 (2016), 602–611.
167. 167 Ogino, S., Chan, A.T., Fuchs, C.S., et al. Molecular pathological epidemiology of colorectal neoplasia: An emerging transdisciplinary and interdisciplinary field. Gut 60 (2011), 397–411.
168. 168 Ogino, S., Lochhead, P., Giovannucci, E., et al. Discovery of colorectal cancer pik3ca mutation as potential predictive biomarker: Power and promise of molecular pathological epidemiology. Oncogene 33 (2014), 2949–2955.
169. 169 Han, P., Liu, G., Lu, X., et al. Cdh1 rs9929218 variant at 16q22.1 contributes to colorectal cancer susceptibility. Oncotarget, 2016.